Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
Patrick R. Sosnay(Perdana University), Karen R. Siklosi(Johns Hopkins University), Fredrick Van Goor(Vertex Pharmaceuticals (United States)), Kyle Kaniecki(Columbia University), Haihui Yu(Vertex Pharmaceuticals (United States)), Neeraj Sharma(Johns Hopkins University), Anabela S. Ramalho(University of Lisbon), Margarida D. Amaral(National Institute of Health Dr. Ricardo Jorge), Ruslan Dorfman(Hospital for Sick Children), Julian Zielenski(Hospital for Sick Children), David L. Masica(Johns Hopkins University), Rachel Karchin(Johns Hopkins University), Linda Millen(The University of Texas Southwestern Medical Center), Philip Thomas(The University of Texas Southwestern Medical Center), George P. Patrinos(University of Patras), Mary Corey(Hospital for Sick Children), Michelle Lewis(Johns Hopkins Berman Institute of Bioethics), Johanna M. Rommens(Hospital for Sick Children), Carlo Castellani(Azienda Ospedaliera Universitaria Integrata Verona), Christopher M. Penland(Cystic Fibrosis Foundation), Garry R. Cutting(Johns Hopkins Medicine)
Cited by 621Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis